MILTENYI BIOTEC GMBH - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:400-500
Total Number of Projects:65
Total Project Funding:400-500
Networking Rank (Reputation):500-600
Networking Rank (Reputation):500-600
Partner Constancy:41
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:900-1000
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
2008
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):900-1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 27
As coordinator: 1
As participant: 26
Sole participant: 0
Coordinator / Participant Ratio: 0.04*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 8.843.224 0 2
2019 0 5.941.004 261.538 3
2018 0 13.294.523 523.018 3
2016 5.989.159 15.483.651 1.788.509 1 2
2015 0 5.750.000 1.345.000 1
2014 0 5.962.644 205.486 1
2013 0 12.554.586 718.751 3
2012 0 27.002.200 1.911.051 6
2011 0 9.981.076 762.980 3
2010 0 22.723.936 755.720 2

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE9
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR6
MEDIZINISCHE HOCHSCHULE HANNOVER6
UNIVERSITY COLLEGE LONDON6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
KING'S COLLEGE LONDON5
MEDIZINISCHE UNIVERSITAET WIEN5
MILTENYI BIOTEC BV & CO KG5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
OSPEDALE SAN RAFFAELE4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ACADEMISCH ZIEKENHUIS GRONINGEN3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
KLINIKUM DER UNIVERSITAET REGENSBURG3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITAET BASEL3
UNIVERSITAET ZUERICH3
UNIVERSITEIT MAASTRICHT3
UNIVERSITEIT TWENTE3
UNIVERSITY OF COPENHAGEN3
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT PASTEUR2
KAROLINSKA INSTITUTE2
LEIDEN UNIVERSITY MEDICAL CENTER2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
OSPEDALE PEDIATRICO BAMBINO GESU2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
TECHNISCHE UNIVERSITAET GRAZ2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE HEBREW UNIVERSITY OF JERUSALEM2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITA VITA SALUTE SAN RAFFAELE2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITE DE LAUSANNE2
UPPSALA UNIVERSITET2
WEIZMANN INSTITUTE OF SCIENCE2
ACADEMISCH ZIEKENHUIS LEIDEN1
ACCELERO BIOANALYTICS1
ADAPTIMMUNE LIMITED1
AFFIMED THERAPEUTICS1
ALCYOMICS1
AMS SENSORS BELGIUM1
AMSTERDAM BIOTHERAPEUTICS UNIT1
APITOPE TECHNOLOGY1
APPLIED NANOPARTICLES SL1
ASTRAZENECA1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
BIOMARKER DESIGN FORSCHUNGS1
BIONTECH1
BLUSENSE DIAGNOSTICS APS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUER RISIKOBEWERTUNG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CANCER RESEARCH UK1
CARTANA AB1
CELL THERAPY CATAPULT LIMITED1
CELLULAR THERAPEUTICS LIMITED1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CENTRO NACIONAL DE INVESTIGACIONESCARDIOVASCULARES CARLOS III1
CHALMERS TEKNISKA HOEGSKOLA AB1
CIMAAS BV1
CLINIT1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CYTOO1
DESCIN BV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIAGNOSTICUM GYARTO ES FORGALMAZO ZARTKORUEN MUKODO RESZVENYTARSASAG1
DSM RESINS BV1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EHT TECHNOLOGIES1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELECTRO SCIENTIFIC INDUSTRIES EUROPE1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPESE VERENIGING VOOR GEN EN CELTHERAPIE IVZW1
EVOLVA BIOTECH AS1
FINOVATIS1
FONDAZIONE TELETHON1
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS1
FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
FYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE1
GATC BIOTECH1
GENETHON1
GENEWERK1
GENOME RESEARCH1
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT1
GLYCOSTEMTHERAPEUTICS BV1
GOETEBORGS UNIVERSITET1

Constancy:

Total number of partners: 308
Partner loyalty:
Frequent Partner: (> 2 projects): 86
Rare Partner: 222
Frequent / Rare Partner Ratio: 0.39

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01INnovative Training in Myeloid Regulatory Cell Therapy INsTRuCTparticipant4.021.02714
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAparticipant4.822.19710
2019-06-01TRAIN-HEART TRAIN-HEARTparticipant3.940.38916
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00011
2019-01-01Quantitative detection of bacterial endotoxin by novel nanotechnological approaches ENDONANOparticipant1.000.6159
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-06-01MAnufacturing of TUmour-REactive Natural Killer cells MATURE-NKparticipant3.351.66214
2018-01-01Transfer of multivirus-specific T-cells following transplantation TRACEparticipant6.000.0008
2016-01-01Chimeric Antigen Receptors (CARs) for Advanced Therapies CARATcoordinator5.989.1598
2016-01-01DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) SCIDNETparticipant6.926.31312
2016-01-01Silicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible Range PIX4LIFEparticipant8.557.33817
2015-09-01Professional cross-priming for ovary and prostate cancer PROCROPparticipant5.750.0007
2014-01-01Upscaling human insulin-producing beta cell production by efficient differentiation and expansion of endoderm progenitors HUMENparticipant5.962.6449
2013-10-01"European stem cell consortium for neural cell replacement, reprogramming and functional brain repair" NEUROSTEMCELLREPAIRparticipant6.000.00013
2013-10-01The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy PLOIDYNETparticipant3.017.79011
2013-01-01Initial Training Network for Neurogical disorders orchestrated by cytoKines NEUROKINEparticipant3.536.79612
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2012-11-01Stem-cell based therapy for kidney repair STELLARparticipant5.998.05013
2012-10-01Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies CELLEUROPEparticipant3.226.31911
2012-10-01Natural Killer Cell-Based Anti-Cancer Immunotherapies: Research training in molecular medicine and biotechnology business NATURIMMUNparticipant3.526.28611
2012-10-01MARie CuRIe AGEing Network MARRIAGEparticipant3.955.36311
2012-01-01Stromal Cell- Immune Cell Interactions in Health and Disease STROMAparticipant4.296.18212
2011-12-01Dopaminergic Neurons for Cell Therapy in Parkinson's Disease DopaNewparticipant728.5962
2011-10-01Recruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes DIABATparticipant5.999.99821
2011-01-01EUROCANCER STEMCELL TRAINING NETWORK EuroCSCTrainingparticipant3.252.48210
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDparticipant11.887.73520
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116

Alias institution names:

  • MILTENYI BIOTEC